Related scientific articles (all)

A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours.

Authors : Schöffski P, Awada A, Dumez H, Gil T, Bartholomeus S, Wolter P, Taton M, Fritsch H, Glomb P, Munzert G
Year : 2012
Journal : Eur. J. Cancer
Volume : 48(2)
Pages : 179-86

Molecular biology in breast cancer: Should molecular classifiers be assessed by conventional tools or by gene expression arrays?

Authors : Fumagalli D, Andre F, Piccart-Gebhart M, Sotiriou C, Desmedt C
Year : 2012
Journal : Crit Rev Oncol Hematol
Volume : 84 supl 1
Pages : e58-69

Cancer du sein et radiothérapie peropératoire par électrons (IOERT)

Authors : Philippson C, Nogaret JM
Year : 2012
Journal : Gynécologie EMC
Volume : 7(4)
Pages : 1-8

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries.

Authors : Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye L, de Azambuja E, Piccart-Gebhart M
Year : 2012
Journal : Ann Oncol
Volume : 23(4)
Pages : 853-859

Bone metastasis in breast cancer: The story of RANK-Ligand.

Authors : Azim HA, Kamal NS
Year : 2012
Journal : J Egypt Natl Canc Inst
Volume : 24(3)
Pages : 107-14

Has removal of excess cysteine led to the evolution of pheomelanin? Pheomelanogenesis as an excretory mechanism for cysteine.

Authors : Galván I, Ghanem G, Møller AP
Year : 2012
Journal : Bioessays
Volume : 34(7)
Pages : 565-8

Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.

Authors : Lagemaat MW, Zechmann CM, Fütterer JJ, Weiland E, Lu J, Villeirs GM, Holshouser BA, van Hecke P, Lemort M, Schlemmer HP, Barentsz JO, Roell SO, Heerschap A, Scheenen TW
Year : 2012
Journal : J Magn Reson Imaging
Volume : 35(1)
Pages : 166-73

Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC).

Authors : Klastersky J, Awada A
Year : 2012
Journal : Crit Rev Oncol Hematol
Volume : 81(1)
Pages : 49-57

Next-generation sequencing in breast cancer: first take home messages.

Authors : Desmedt C, Voet T, Sotiriou C, Campbell PJ
Year : 2012
Journal : Curr Opin Oncol
Volume : 24(6)
Pages : 597-604

Exploitation de la spectrométrie de masse en microbiologie : une révolution.

Authors : Martiny D, Vandenberg O
Year : 2012
Journal : J immbio
Volume : 27(4)
Pages : 177-84

EORTC 24051: Unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma.

Authors : Lalami Y, Specenier PM, Awada A, Lacombe D, Liberatoscioli C, Fortpied C, El-Hariry I, Bogaerts J, Andry G, Langendijk HJ, Vermorken JB
Year : 2012
Journal : Radiother Oncol
Volume : 105(2)
Pages : 238-40

Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.

Authors : Azim HA, Santoro L, Russell-Edu W, Pentheroudakis G, Pavlidis N, Peccatori FA
Year : 2012
Journal : Cancer Treat Rev
Volume : 38(7)
Pages : 834-42

MDM4 is a key therapeutic target in cutaneous melanoma.

Authors : Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S, Zwolinska A, Haupt S, de Lange J, Yip D, Goydos J, Haigh JJ, Haupt Y, Larue L, Jochemsen A, Shi H, Moriceau G, Lo RS, Ghanem G, Shackleton M, Bernal F, Marine JC
Year : 2012
Journal : Nat. Med.
Volume : 18
Pages : 1239-47

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

Authors : Baselga J, Campone M, Piccart-Gebhart M, Burris HA, Rugo HS, Sahmoud T, Noguchi S, Gnant M, Pritchard KI, Lebrun F, Beck JT, Ito Y, Yardley D, Deleu I, Perez A, Bachelot T, Vittori L, Xu Z, Mukhopadhyay P, Lebwohl D, Hortobagyi GN
Year : 2012
Journal : N Engl J Med
Volume : 366(6)
Pages : 520-9

Treatment Options in Anthracycline and/or Taxane Pretreated Patients with Metastatic Breast Cancer.

Authors : Pugliano L, de Azambuja E
Year : 2012
Journal : Onkologie
Volume : 35(9)
Pages : 476-8

Causes of death and incidence of life-support techniques limitations oncological patients dying in the ICU : a retrospective study.

Authors : Meert AP, Dept S, Berghmans T, Sculier JP
Year : 2012
Journal : Journal of Palliative Care & Medicine
Volume : 2-3
Pages : 4 pages

Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891.

Authors : Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L, de Raucourt D, Langendijk JA
Year : 2012
Journal : Ann Oncol
Volume : 23(10)
Pages : 2708-2714

Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.

Authors : Anghel SI, Correa-Rocha R, Correa-Rochal R, Budinska E, Boligan KF, Boliganl KF, Abraham S, Colombetti S, Fontao L, Mariotti A, Rimoldi D, Ghanem G, Fisher DE, Lévy F, Delorenzi M, Piguet V
Year : 2012
Journal : Pigment Cell Melanoma Res
Volume : 25(4)
Pages : 482-7

Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells.

Authors : Herraiz C, Journe F, Ghanem G, Jiménez-Cervantes C, García-Borrón JC
Year : 2012
Journal : Int. J. Biochem. Cell Biol.
Volume : 44(12)
Pages : 2244-2252

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence.

Authors : Rossari JR, Metzger-Filho O, Paesmans M, Saini KS, Gennari A, de Azambuja E, Piccart-Gebhart M
Year : 2012
Journal : J Oncol
Volume : 2012
Pages : 417673